Equity Instruments (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2012 Person	Dec. 31, 2011
Equity instruments (Additional Textual) [Abstract]
Compensation Costs, Unrecognized	$ 50,000	$ 315,000
Tax benefits attributable to stock based compensation expense recognized	41,000	404,000
Converted common stock	59,451,836	59,251,836
Compensation Costs Related to Warrants, Derecognized	1,000	283,000
Equity instrument (Textual) [Abstract]
Number of warrants cancelled in exchange of share issue	120
Number of directors to be appointed	5
Options for ISOs granted term	10 years
Dividend Issued Treated as conversion Percent	50.00%
Common Stock [Member]
Equity instruments (Additional Textual) [Abstract]
Conversion rate of preferred stock into common stock	316.28
Stock Option [Member]
Equity instruments (Additional Textual) [Abstract]
Compensation costs recognized	235,000	1,200,000
Maximum [Member] | Stock Option [Member]
Equity instruments (Additional Textual) [Abstract]
Compensation Costs, Expected Weighted-Average period	19 months
Minimum [Member] | Stock Option [Member]
Equity instruments (Additional Textual) [Abstract]
Compensation Costs, Expected Weighted-Average period	11 months
Series C convertible preferred stock [Member]
Equity instruments (Additional Textual) [Abstract]
Liquidation preference per share value	$ 250
Liquidation preference value	2,600,000	2,600,000
Warrants [Member]
Equity instruments (Additional Textual) [Abstract]
Tax benefits attributable to stock based compensation expense recognized		624,000
Warrants granted	125,000
Compensation costs recognized	2,000	1,700,000
Reversal of tax benefit and valuation Allowance related to derecognized compensation costs	6,000
Compensation Costs Related to Warrants, Derecognized	25,000
Warrants [Member] | Maximum [Member]
Equity instruments (Additional Textual) [Abstract]
Compensation Costs, Expected Weighted-Average period		31 months
Terms of warrants	36 months
Warrants [Member] | Minimum [Member]
Equity instruments (Additional Textual) [Abstract]
Compensation Costs, Expected Weighted-Average period	12 months
Terms of warrants	24 months
Series D convertible preferred stock [Member]
Equity instruments (Additional Textual) [Abstract]
Series D convertible preferred stock, authorized shares	7,000
Preferred stock, shares issued	250
Preferred stock, vesting period	10 years
Convertible preferred stock, shares issued upon conversion	100,000
Preferred Stock Voting Rights	Equal to 500,000 shares of common stock
Compensation Costs, Expected Weighted-Average period	9 years
Compensation costs recognized	$ 3,400,000
Stock Incentive Compensation Plans [Member]
Equity instruments (Additional Textual) [Abstract]
Options available for grant	44,448,000
Options outstanding	6,518,000
Options exercisable	6,201,334
Stock Incentive Compensation Plans [Member] | Maximum [Member]
Equity instruments (Additional Textual) [Abstract]
Common stock, shares authorized	52,000,000
Non Qualified Directors Plan [Member]
Equity instruments (Additional Textual) [Abstract]
Options available for grant	801,668
Options outstanding	100,000
Options exercisable	60,000
Non qualified stock options to our non employee directors	1,000,000
Options granted annually	15,000
Non Qualified Directors Plan [Member] | Initial [Member]
Equity instruments (Additional Textual) [Abstract]
Initial options granted	25,000